Enhance your clinical approach to ATTR-CM by exploring its presentation across diverse populations, including differences in prevalence and the unique challenges women and minority populations may face in receiving a timely diagnosis. Discover practical, team-based strategies and culturally responsive communication techniques to improve diagnostic decision-making, strengthen patient engagement, and promote equitable management.

Learning Objectives

  1. Recognize clinical and echocardiographic red flags of ATTR-CM across diverse populations including key signs and imaging features to differentiate from other causes
  2. Describe the epidemiology of ATTR-CM, including the higher varying prevalence based on ancestry, and explain how implicit bias, access barriers, and misattribution of symptoms contribute to delayed diagnosis in minority populations (including women)
  3. Discuss equitable, team-based strategies application of evidence-based diagnostic pathways and culturally responsive communication strategies to promote timely testing, referral, and patient engagement in diverse clinical settings.

 

 

CE certificate available upon successful completion of the post-test and program evaluation.

Non-Member Price

$0

Member Price

$0

CE Contact Hours

0.75

Pharmacology CE Hours

0.0

Jeremy Slivnick

MD, FACC, FASE, FSCMR

Morgan Lewis

BSN, RN

AANP-provider-logo

Accreditation:

PCNA is accredited by the American Association of Nurse Practitioners® as an approved provider of nurse practitioner continuing education. Provider number: 030602. This activity is approved for 0.75 contact hour(s) (which includes 0.0 hour(s) of pharmacology).